Prevención Cuaternaria y PSA
El US Preventive Task Force revisa sus recomendaciones respecto al cribado de cáncer de próstata en hombres asintomáticos, menores de 75 años y desaconseja la realización de PSA.
No produce beneficios, no salva vidas y agrega yatrogenia.
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer. This is a grade D recommendation.
Conclusion: Prostate-specific antigen–based screening results in small or no reduction in prostate cancer–specific mortality and is associated with harms related to subsequent evaluation and treatments, some of which may be unnecessary.
Ver link: http://www.uspreventiveservicestaskforce.org/uspstf12/prostate/prostateart.htm
Mas no siempre es mejor.
Deja tu próstata en paz!
Mas.
Vea la nota al vicepresidente ejecutivo de la American Cancer Society, Otis Webb Brawley, en el New York Times
http://www.nytimes.com/2011/10/09/magazine/can-cancer-ever-be-ignored.html?_r=2&ref=magazine
“I’m not against prostate-cancer screening,” Brawley says. “I’m against lying to men. I’m against exaggerating the evidence to get men to get screened. We should tell people what we know, what we don’t know and what we simply believe.”
No produce beneficios, no salva vidas y agrega yatrogenia.
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer. This is a grade D recommendation.
Conclusion: Prostate-specific antigen–based screening results in small or no reduction in prostate cancer–specific mortality and is associated with harms related to subsequent evaluation and treatments, some of which may be unnecessary.
Ver link: http://www.uspreventiveservicestaskforce.org/uspstf12/prostate/prostateart.htm
Mas no siempre es mejor.
Deja tu próstata en paz!
Mas.
Vea la nota al vicepresidente ejecutivo de la American Cancer Society, Otis Webb Brawley, en el New York Times
http://www.nytimes.com/2011/10/09/magazine/can-cancer-ever-be-ignored.html?_r=2&ref=magazine
“I’m not against prostate-cancer screening,” Brawley says. “I’m against lying to men. I’m against exaggerating the evidence to get men to get screened. We should tell people what we know, what we don’t know and what we simply believe.”
Comentarios